Rocket Lab pushes into medium-lift launches with Neutron, aiming to expand beyond small satellites and capture growing demand for larger, complex space missions.
RKLB climbs 10.1% in six months as defense demand and backlog growth drive momentum, but premium valuation and government exposure cloud near-term outlook.
With SpaceX ‘s confidential IPO filing and reports of a targeted valuation above $1.75 trillion — investors have boosted nearly every space stock in sight.
RKLB balances a $1.85B backlog and rising defense demand with execution risks from Neutron delays, margin pressure, and supplier constraints shaping its outlook.
Rocket Lab taps rising hypersonic demand with HASTE missions and SDA wins, boosting backlog visibility while supplier constraints and execution timing remain key risks.
RKLB's $1.85B backlog and rising launch cadence set a clear 2026 revenue path, even as timing and mix create near-term volatility in results.
Rocket Lab ( NASDAQ :RKLB | RKLB Price Prediction ) was worth a mere $4.1 per share back in late March 2024.
Rocket Lab's chief performance indicator is the “time horizon” that its CEO, Sir Peter Beck, is able to focus investors on. This aspect isn't talked about much and is mostly hidden, yet it is the key factor influencing Rocket Lab's stock.
The company says it will take the money that would have gone toward Beck's future wages and bonuses and put it toward R&D projects.
Rocket Lab USA (NASDAQ:RKLB | RKLB Price Prediction) shares are up 6% in early trading today, climbing from an opening of $57.38 to $60 and change.
Department of Defense awards Rocket Lab $190 million under Kratos-led hypersonics contract. Rocket Lab will launch 20 HASTE suborbital rocket missions at a cost of $9.5 million each.
The latest trading day saw Rocket Lab Corporation (RKLB) settling at $60.93, representing a -7.6% change from its previous close.